Exploration of tumor growth regression of quinoa and chia oil nanocapsules via the control of PIK3CA and MYC expression, anti-inflammation and cell proliferation inhibition, and their hepatorenal safety in rat breast cancer model

Bulletin of the National Research Centre

Table 2 GC/MS analysis of the unsaponifiable fraction of quinoa oil

No.	R_t	Compounds	BP	M +	Molecular formula	Area %
1	9.34	1-Octanol	57	130	C₈H₁₈O	6.84
2	14.06	Ethyl(ethyl thio)acetate	75	148	C₆H₁₂O₂S	3.80
3	14.78	2-Hydroxy-3-methylsuccinic acid	103	148	C₅H₈O₅	0.36
4	19.35	1,1,3,3-Tetra ethoxy propane	103	220	C₁₁H₂₄O₄	6.84
5	19.95	Trans-Caryophyllene	79	204	C₁₅H₂₄	0.58
6	22.24	Butylated hydroxytoluene	205	220	C₁₅H₂₄O	3.23
7	24.12	Octadecane	57	254	C₁₆H₃₄	0.30
8	24.23	2-Phenyl decane	105	218	C₁₆H₂₆	0.33
9	25.19	2 -Phenyl undecane	105	232	C₁₇H₂₈	0.30
10	28.62	2-Phenyl dodecane	105	246	C₁₈H₃₀	0.26
11	29.38	6,10,14-trimethyl-2-Pentadecanone	58	268	C₁₈H₃₆O	1.26
12	35.34	Docosene	55	308	C₂₂H₄₄	0.61
13	36.03	Docosane	57	310	C₂₂H₄₆	0.78
14	37.34	Ethyl isoallocholate	69	436	C₂₆H₄₄O₅	0.36
15	41.07	Pentacosane	57	352	C₁₅H₃₂	2.89
16	44.14	Hexacosane	57	366	C₁₆H₃₄	1.43
17	45.61	Triacontane	57	420	C₃₀H₄₆	0.34
18	46.19	Squalene	59	410	C₃₀H₅₀	51.87
19	46.49	Nerolidol	55	222	C₁₅H₂₆O	0.28
20	53.67	Stigmast-5-en-3-ol	55	414	C₂₉H₅₀O	0.59
		Identified compounds			–	83.25
		Non-identified			–	16.75